Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Cash Flows

v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (173,767) $ (476,303)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of debt discount 34,175 78,711
Depreciation 885
Stock based compensation 12,404
Credit loss expense 23,800
Changes in operating assets and liabilities:    
Accounts receivable (1,200) 173,683
Prepaid expenses and other assets (117,236) (42,817)
Accounts payable and accrued liabilities (6,760) (140,445)
Deferred revenue (1,250) (21,250)
Net cash used in operating activities (252,749) (404,621)
Cash flows from investing activities:    
Additions to intangible assets (65,413)
Net cash used in investing activities: (65,413)
Cash flows from financing activities:    
Proceeds from loans payable, net 1,385,000
Payments on loans payable (14,617)
Proceeds from the exercise of warrants, net of costs 15,502
Net cash provided by financing activities 15,502 1,370,383
Net (decrease) increase in cash (302,660) 965,762
Cash, beginning of period 1,644,439 106,654
Cash, end of period 1,341,779 1,072,416
Supplemental disclosures of cash flow information:    
Cash paid for interest 56
Cash paid for income taxes
Non-cash investing and financing activities:    
Shares issued for conversion of convertible loans and interest 42,857 47,283
Shares issued for accrued legal settlement 148,410
Warrants issued in conjunction with convertible loans $ 1,385,000